Published in Infect Immun on April 01, 1976
Radiation leukemia in C57BL/6 mice. I. Lack of serological evidence for the role of endogenous ecotropic viruses in pathogenesis. J Exp Med (1976) 1.32
Host genes conferring resistance to a central nervous system disease induced by a polytropic recombinant Friend murine retrovirus. J Virol (1990) 1.07
Genetic control of natural immunity to ecotropic mouse leukemia viruses: immune response genes. Infect Immun (1976) 0.95
Genetic control of resistance to tumors. Am J Pathol (1978) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Plaque assay techniques for murine leukemia viruses. Virology (1970) 29.21
Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses. Virology (1975) 10.56
Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice. J Exp Med (1972) 6.52
The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med (1971) 6.06
GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS. Lancet (1964) 4.83
Genetic mapping of a murine leukemia virus-inducing locus of AKR mice. Science (1972) 3.81
Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv-1 b strains of mice. J Exp Med (1972) 3.47
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels. J Exp Med (1973) 2.31
Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus. Proc Natl Acad Sci U S A (1974) 2.27
Autogenous immunity to endogenous RNA tumor virus. Identification of antibody reactivity to select viral antigens. J Exp Med (1974) 2.10
Antibody to leukemia virus: widespread occurrence in inbred mice. Science (1974) 1.91
Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection. J Natl Cancer Inst (1968) 1.79
Endogenous oncornaviruses in chemically induced transformation. I. Transformation independent of virus production. Virology (1975) 1.55
Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses. J Immunol (1975) 1.34
Immune response in the mouse to endogenous leukemia viruses. Cold Spring Harb Symp Quant Biol (1975) 1.22
Wild-type Gross leukemia virus. 3. Serological tests as indicators of leukemia risk. J Natl Cancer Inst (1968) 1.16
Autogenous immunity to endogenous RNA tumor virus: differential reactivities of immunoglobulins M and G to virus envelope antigens. J Virol (1974) 1.11
Autogenous immunity to endogenous RNA tumor virus: chronic humoral immune response to virus envelope antigens in B6C3F1 mice. J Natl Cancer Inst (1974) 1.07
Genetic control of natural immunity to ecotropic mouse leukemia viruses: immune response genes. Infect Immun (1976) 0.95
Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens. Cancer Res (1975) 0.94
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun (1982) 5.54
Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis (1984) 5.40
A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology (1974) 5.01
The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses. Virology (1979) 4.59
Cost-effectiveness analysis in a setting of budget constraints--is it equitable? N Engl J Med (1996) 4.13
Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res (1972) 3.23
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10
Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins. Virology (1979) 2.62
Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis. J Infect Dis (1983) 2.60
Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA. J Clin Microbiol (1983) 2.50
Transcription of mouse mammary tumor virus genes in tissues from high and low tumor incidence mouse strains. J Mol Biol (1973) 2.45
Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39
Oncogenicity of AKR endogenous leukemia viruses. J Virol (1978) 2.31
Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus. Virology (1968) 2.26
Common properties of the oncogenic RNA viruses (oncornaviruses). Virology (1970) 2.20
Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol (1996) 2.04
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. N Engl J Med (1988) 1.97
Antibody to leukemia virus: widespread occurrence in inbred mice. Science (1974) 1.91
The hypotonic upper airway in obstructive sleep apnea: role of structures and neuromuscular activity. Am J Respir Crit Care Med (1998) 1.90
Order of magnitude smaller limit on the electric dipole moment of the electron. Science (2013) 1.89
Mammary tumour virus specific nucleotide sequences in mouse DNA. Nat New Biol (1972) 1.87
Endogenous ecotropic mouse type C viruses deficient in replication and production of XC plaques. J Virol (1976) 1.87
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Characterization of monoclonal antibodies to Treponema pallidum. J Immunol (1985) 1.83
Serological analysis of the deoxyribonucleic acid polymerase of avian oncornaviruses. II. Comparison of avian deoxyribonucleic acid polymerases. J Virol (1972) 1.75
Oncornaviruses produced by murine leukemia cells in culture. Virology (1977) 1.73
Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest (1994) 1.72
Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies. Virology (1980) 1.72
Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer (1983) 1.71
Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology (1994) 1.64
Body size and risk of breast cancer. Am J Epidemiol (1997) 1.63
Viral proteins expressed on the surface of murine leukemia cells. J Virol (1977) 1.60
Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol (1995) 1.59
Endogenous oncornaviruses in chemically induced transformation. I. Transformation independent of virus production. Virology (1975) 1.55
Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells. J Virol (1977) 1.54
Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC. J Immunol (1990) 1.54
The inclusion of patient testimonials in decision aids: effects on treatment choices. Med Decis Making (2001) 1.54
Helical nucleocapsid structure of the oncogenic ribonucleic acid viruses (oncornaviruses). J Virol (1971) 1.48
Omission bias and pertussis vaccination. Med Decis Making (1994) 1.48
A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics (1980) 1.43
Serological and structural properties of Mason-Pfizer monkey virus isolated from the mammary tumor of a Rhesus monkey. Proc Natl Acad Sci U S A (1971) 1.43
Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci U S A (2001) 1.41
Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study. J Immunol (1981) 1.41
Antibody response of mice to chemically induced tumors. Proc Natl Acad Sci U S A (1978) 1.41
Biosynthesis and metabolism of viral proteins expressed on the surface of murine leukemia virus-infected cells. Virology (1978) 1.39
Radioimmunoguided surgery benefits for recurrent colorectal cancer. Ann Surg Oncol (1997) 1.39
Insecticide-induced lupus erythematosus. Int J Dermatol (1994) 1.38
Regulation of growth plate chondrogenesis by bone morphogenetic protein-2. Endocrinology (2001) 1.37
Purification of IMP:pyrophosphate phosphoribosyltransferases, catalytically incompetent enzymes in Lesch-Nyhan disease. Proc Natl Acad Sci U S A (1971) 1.36
Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35
Effect of 3-amino-1,2,4-triazole on the stimulation of hepatic microsomal heme synthesis and induction of hepatic microsomal oxidases produced by phenobarbital. Mol Pharmacol (1969) 1.35
Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses. J Immunol (1975) 1.34
The colonoscopic miss rate and true one-year recurrence of colorectal neoplastic polyps. Polyp Prevention Study Group. Am J Gastroenterol (1999) 1.33
Immune response of the mouse to the major core protein (p30) of ecotropic leukemia viruses. J Immunol (1976) 1.31
Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. Science (1980) 1.30
Specific in vivo localization of monoclonal antibodies directed against the Thy 1.1 antigen. J Immunol (1980) 1.29
Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control (1995) 1.27
Serological identification of hamster oncornaviruses. Nat New Biol (1971) 1.26
The role of thrombin in preterm parturition. Am J Obstet Gynecol (2001) 1.26
Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer (1997) 1.25
Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25
Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer (1996) 1.24
Enhanced protein synthesis in a cell-free system from hypertrophied skeletal muscle. Science (1967) 1.23
Immune response in the mouse to endogenous leukemia viruses. Cold Spring Harb Symp Quant Biol (1975) 1.22
Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology (1998) 1.22
Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2). J Exp Med (1979) 1.21
Early life risk factors for prostate cancer: a population-based case-control study in Sweden. Cancer Epidemiol Biomarkers Prev (1995) 1.20
Lysis of leukemia cells by spleen cells of normal mice. Proc Natl Acad Sci U S A (1975) 1.20
Characteristics of the structural components of the mouse mammary tumor virus. I. Morphological and biochemical studies. Virology (1971) 1.18
Aortic homograft replacement of the mitral valve in sickle cell trait. J Thorac Cardiovasc Surg (1970) 1.18
Early-life risk indicators of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1994) 1.17
Clinical reasoning and cognitive processes. Med Decis Making (1988) 1.16
A new spectral intermediate associated with cytochrome P-450 function in liver microsomes. Biochem Biophys Res Commun (1971) 1.14
Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst (1995) 1.14
Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice. J Virol (1982) 1.12
Effect of drugs on heme synthesis in the liver. Metabolism (1971) 1.12
Recent oral contraceptive use and risk of breast cancer (United States) Cancer Causes Control (1996) 1.10
Lifestyle factors and prostate cancer risk: a case-control study in Sweden. Cancer Epidemiol Biomarkers Prev (1996) 1.10
Immunohistochemical localization of glutathione S-transferases in livers of untreated rats. J Biol Chem (1982) 1.09
Tethered-function analysis reveals that elF4E can recruit ribosomes independent of its binding to the cap structure. RNA (2001) 1.09
Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus. J Gen Virol (1999) 1.08
Differential regulation of the expression of transporters associated with antigen processing, TAP1 and TAP2, by cytokines and lipopolysaccharide in primary human macrophages. Inflamm Res (2002) 1.08
A soluble antigen of the mammary tumor virus. Virology (1967) 1.07
Do nonpatients underestimate the quality of life associated with chronic health conditions because of a focusing illusion? Med Decis Making (2001) 1.05
Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer (1985) 1.05
Cell surface antigens associated with murine leukemia virus: definition of the GL and GT antigenic systems. J Virol (1973) 1.05
Presence of T cell-associated surface antigens on murine NK cells. J Immunol (1979) 1.03
The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens. J Exp Med (1979) 1.03
Selective neutralization of ecotropic murine leukemia virus by monoclonal antibodies: localization of a site on the gp70 protein associated with ecotropism. Virology (1981) 1.03
Cellular changes in the thymuses of preleukemic AKR mice: correlation with changes in the expression of murine leukemia viruses. Cell (1977) 1.03